Insulin aspart, recombinant Subcutaneous and Kadian ER
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Kadian ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: morphine
Brand name: Kadian, Arymo ER, MorphaBond ER, Avinza, MS Contin, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Kadian
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Kaitlib FE
- Insulin aspart, recombinant Subcutaneous-Kaitlib FE birth control
- Insulin aspart, recombinant Subcutaneous-Kaletra
- Insulin aspart, recombinant Subcutaneous-Kaletra (Lopinavir and Ritonavir Oral Solution)
- Insulin aspart, recombinant Subcutaneous-Kaletra (Lopinavir and Ritonavir Tablets)
- Insulin aspart, recombinant Subcutaneous-Kaletra Oral Solution
- Kadian ER-Insulin degludec
- Kadian ER-Insulin Degludec (U-100) Prefilled Pens
- Kadian ER-Insulin Degludec (U-100) Vials
- Kadian ER-Insulin Degludec (U-200) Prefilled Pens
- Kadian ER-Insulin degludec and liraglutide
- Kadian ER-Insulin degludec and liraglutide Subcutaneous